Free Trial
→ The SpaceX supplier that shipped 5 billion chips to Starlink (From Weiss Ratings) (Ad)tc pixel Free UPHL Stock Alerts

UpHealth (UPHL) Competitors

$0.0001 0.00 (-50.00%)
As of 09:30 AM Eastern
Compare

UPHL vs. BTTX, ACONW, AONC, DHACW, and LFMDP

Should you buy UpHealth stock or one of its competitors? MarketBeat compares UpHealth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with UpHealth include Better Therapeutics (BTTX), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), and LifeMD (LFMDP). These companies are all part of the "healthcare" industry.

How does UpHealth compare to Better Therapeutics?

UpHealth (NYSE:UPHL) and Better Therapeutics (NASDAQ:BTTX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.

Company Net Margins Return on Equity Return on Assets
UpHealthN/A N/A N/A
Better Therapeutics N/A N/A N/A

56.1% of UpHealth shares are owned by institutional investors. Comparatively, 34.0% of Better Therapeutics shares are owned by institutional investors. 34.2% of UpHealth shares are owned by company insiders. Comparatively, 51.4% of Better Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Better Therapeutics has lower revenue, but higher earnings than UpHealth. Better Therapeutics is trading at a lower price-to-earnings ratio than UpHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UpHealth$130M0.00-$56.42M$1.470.00
Better TherapeuticsN/AN/A-$39.76M-$0.78N/A

In the previous week, UpHealth's average media sentiment score of 0.00 equaled Better Therapeutics'average media sentiment score.

Company Overall Sentiment
UpHealth Neutral
Better Therapeutics Neutral

UpHealth has a beta of 0.47, meaning that its share price is 53% less volatile than the broader market. Comparatively, Better Therapeutics has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market.

Summary

UpHealth beats Better Therapeutics on 4 of the 7 factors compared between the two stocks.

How does UpHealth compare to Aclarion?

Aclarion (NASDAQ:ACONW) and UpHealth (NYSE:UPHL) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings, risk and media sentiment.

In the previous week, Aclarion's average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score.

Company Overall Sentiment
Aclarion Neutral
UpHealth Neutral

56.1% of UpHealth shares are held by institutional investors. 34.2% of UpHealth shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
AclarionN/A N/A N/A
UpHealth N/A N/A N/A

Aclarion has higher earnings, but lower revenue than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aclarion$77.88KN/AN/AN/AN/A
UpHealth$130M0.00-$56.42M$1.470.00

Summary

UpHealth beats Aclarion on 3 of the 3 factors compared between the two stocks.

How does UpHealth compare to American Oncology Network?

UpHealth (NYSE:UPHL) and American Oncology Network (NASDAQ:AONC) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings.

In the previous week, American Oncology Network had 2 more articles in the media than UpHealth. MarketBeat recorded 2 mentions for American Oncology Network and 0 mentions for UpHealth. UpHealth's average media sentiment score of 0.00 beat American Oncology Network's score of -0.90 indicating that UpHealth is being referred to more favorably in the media.

Company Overall Sentiment
UpHealth Neutral
American Oncology Network Negative

56.1% of UpHealth shares are owned by institutional investors. 34.2% of UpHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
UpHealthN/A N/A N/A
American Oncology Network N/A N/A N/A

American Oncology Network has higher revenue and earnings than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UpHealth$130M0.00-$56.42M$1.470.00
American Oncology Network$1.34BN/AN/AN/AN/A

Summary

UpHealth beats American Oncology Network on 3 of the 5 factors compared between the two stocks.

How does UpHealth compare to Digital Health Acquisition?

Digital Health Acquisition (NASDAQ:DHACW) and UpHealth (NYSE:UPHL) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

56.1% of UpHealth shares are owned by institutional investors. 34.2% of UpHealth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Digital Health Acquisition has higher earnings, but lower revenue than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Digital Health AcquisitionN/AN/AN/AN/AN/A
UpHealth$130M0.00-$56.42M$1.470.00

In the previous week, Digital Health Acquisition's average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score.

Company Overall Sentiment
Digital Health Acquisition Neutral
UpHealth Neutral

Company Net Margins Return on Equity Return on Assets
Digital Health AcquisitionN/A N/A N/A
UpHealth N/A N/A N/A

Summary

UpHealth beats Digital Health Acquisition on 3 of the 3 factors compared between the two stocks.

How does UpHealth compare to LifeMD?

LifeMD (NASDAQ:LFMDP) and UpHealth (NYSE:UPHL) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations and media sentiment.

Company Net Margins Return on Equity Return on Assets
LifeMDN/A N/A N/A
UpHealth N/A N/A N/A

LifeMD has higher revenue and earnings than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeMD$193.33MN/AN/AN/AN/A
UpHealth$130M0.00-$56.42M$1.470.00

56.1% of UpHealth shares are owned by institutional investors. 34.2% of UpHealth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, LifeMD had 1 more articles in the media than UpHealth. MarketBeat recorded 1 mentions for LifeMD and 0 mentions for UpHealth. LifeMD's average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score.

Company Overall Sentiment
LifeMD Neutral
UpHealth Neutral

Summary

LifeMD and UpHealth tied by winning 2 of the 4 factors compared between the two stocks.

Get UpHealth News Delivered to You Automatically

Sign up to receive the latest news and ratings for UPHL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UPHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UPHL vs. The Competition

Export
MetricUpHealthHealth services IndustryMedical SectorNYSE Exchange
Market Cap$2K$1.24M$6.39B$23.29B
Dividend YieldN/AN/A2.76%4.10%
P/E Ratio0.00N/A20.9831.08
Price / Sales0.000.00559.6325.18
Price / CashN/AN/A43.4925.12
Price / Book0.000.0010.414.79
Net Income-$56.42M-$56.42M$3.57B$1.07B
7 Day PerformanceN/AN/A4.39%3.21%
1 Month PerformanceN/AN/A1.84%2.46%
1 Year PerformanceN/AN/A34.86%30.10%

UpHealth Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UPHL
UpHealth
N/A$0.00
-50.0%		N/A-66.7%$2K$130MN/A1,750
BTTX
Better Therapeutics
N/A$0.00
flat		N/AN/A$4KN/AN/A40
ACONW
Aclarion
N/A$0.03
-12.7%		N/A+4.7%$0.00$75.73KN/A7
AONC
American Oncology Network
N/A$12.00
flat		N/A+95.1%$0.00$1.34BN/A1,520
DHACW
Digital Health Acquisition
N/A$0.05
flat		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:UPHL) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners
Nevada gold explorer near Kinross district draws attention
Gold has surged past $5,300 per ounce, with Goldman Sachs and JPMorgan forecasting $6,000+ by end of 2026. Cen...
Wall Street Logic | Sponsoredtc pixel
Opportunity Forming in a U.S. Supply-Chain Weak Spot?
America has a supply-chain problem with graphite - demand is climbing while dependence on foreign sources rema...
i2i Marketing Group, LLC | Sponsoredtc pixel
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
No. You’re not imagining it…
Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...
Porter & Company | Sponsoredtc pixel
Trump Is Eyeing the Biggest Monetary Shift Since Nixon
On August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...
Americas Gold Company | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
I was right about SpaceX
Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...
Brownstone Research | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
Futurist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...
Eagle Publishing | Sponsoredtc pixel